63 related articles for article (PubMed ID: 8609886)
1. Separation of resistance to antitumor diarylsulfonylurea agents from collateral sensitivity to mitochondrial toxins.
Shu LL; Houghton PJ
Mol Pharmacol; 1996 Apr; 49(4):595-601. PubMed ID: 8609886
[TBL] [Abstract][Full Text] [Related]
2. Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
Sosinski J; Thakar JH; Germain GS; Dias P; Harwood FC; Kuttesch JF; Houghton PJ
Mol Pharmacol; 1994 May; 45(5):962-70. PubMed ID: 7910660
[TBL] [Abstract][Full Text] [Related]
3. Proliferation-dependent and -independent cytotoxicity by antitumor diarylsulfonylureas. Indication of multiple mechanisms of drug action.
Sosinski J; Thakar JH; Germain GS; Harwood FC; Houghton PJ
Biochem Pharmacol; 1993 May; 45(10):2135-42. PubMed ID: 8512595
[TBL] [Abstract][Full Text] [Related]
4. Evidence for mitochondrial localization of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)urea in human colon adenocarcinoma cells.
Houghton PJ; Bailey FC; Houghton JA; Murti KG; Howbert JJ; Grindey GB
Cancer Res; 1990 Feb; 50(3):664-8. PubMed ID: 2297707
[TBL] [Abstract][Full Text] [Related]
5. Effect of antitumor diarylsulfonylureas on in vivo and in vitro mitochondrial structure and functions.
Thakar JH; Chapin C; Berg RH; Ashmun RA; Houghton PJ
Cancer Res; 1991 Dec; 51(23 Pt 1):6286-91. PubMed ID: 1933889
[TBL] [Abstract][Full Text] [Related]
6. N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cells.
Houghton PJ; Bailey FC; Germain GS; Grindey GB; Witt BC; Houghton JA
Cancer Res; 1990 Jan; 50(2):318-22. PubMed ID: 2295071
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the intracellular distribution and binding in human adenocarcinoma cells of N-(4-azidophenylsulfonyl)-N'-(4-chlorophenyl)urea (LY219703), a photoaffinity analogue of the antitumor diarylsulfonylurea sulofenur.
Houghton PJ; Sosinski J; Thakar JH; Boder GB; Grindey GB
Biochem Pharmacol; 1995 Mar; 49(5):661-8. PubMed ID: 7887981
[TBL] [Abstract][Full Text] [Related]
8. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Kumar A; Soprano DR; Parekh HK
Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
[TBL] [Abstract][Full Text] [Related]
9. Differential induction of apoptosis and MAP kinase signaling by mitochondrial toxicants in drug-sensitive compared to drug-resistant B-lineage lymphoid cell lines.
O'Brien KA; Muscarella DE; Bloom SE
Toxicol Appl Pharmacol; 2001 Aug; 174(3):245-56. PubMed ID: 11485385
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of sulofenur and a second generation diarylsulfonylurea, N-[5-(2,3-dihydrobenzofuryl)sulfonyl]-N'-(3,4-dichlorophenyl)urea (LY295501), against colon adenocarcinoma xenografts.
Houghton PJ; Cheshire PJ; Myers L; Lutz L; Toth J; Grindey GB; Houghton JA
Anticancer Drugs; 1995 Apr; 6(2):317-23. PubMed ID: 7795279
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells.
Zhou BS; Hsu NY; Pan BC; Doroshow JH; Yen Y
Cancer Res; 1995 Mar; 55(6):1328-33. PubMed ID: 7882331
[TBL] [Abstract][Full Text] [Related]
12. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
Moscow JA; Townsend AJ; Cowan KH
Mol Pharmacol; 1989 Jul; 36(1):22-8. PubMed ID: 2747627
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
[TBL] [Abstract][Full Text] [Related]
14. Modification and inheritance of pleiotropic cross resistance and collateral sensitivity in Saccharomyces cerevisiae.
Rank GH; Robertson AJ; Phillips KL
Genetics; 1975 Jul; 80(3):783-93. PubMed ID: 782999
[TBL] [Abstract][Full Text] [Related]
15. cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.
Ara G; Kusumoto T; Korbut TT; Cullere-Luengo F; Teicher BA
Cancer Res; 1994 Mar; 54(6):1497-502. PubMed ID: 8137254
[TBL] [Abstract][Full Text] [Related]
16. Effect of albumin on antitumor activity of diarylsulfonylureas.
Schultz RM; Andis SL; Toth JE; Boder GB; Rinzel SM; Grindey GB
Anticancer Res; 1993; 13(6A):1939-43. PubMed ID: 8297099
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mitochondrial function in HL60 cells is associated with an increased apoptosis and expression of CD14.
Mills KI; Woodgate LJ; Gilkes AF; Walsh V; Sweeney MC; Brown G; Burnett AK
Biochem Biophys Res Commun; 1999 Sep; 263(2):294-300. PubMed ID: 10491287
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria-targeting drug oligomycin blocked P-glycoprotein activity and triggered apoptosis in doxorubicin-resistant HepG2 cells.
Li YC; Fung KP; Kwok TT; Lee CY; Suen YK; Kong SK
Chemotherapy; 2004 Jun; 50(2):55-62. PubMed ID: 15211078
[TBL] [Abstract][Full Text] [Related]
20. [Fully length MDR1 cDNA transfer conferring resistance to adriamycine on sensitive cells GLC].
Zhou Z; Lin C; Chen F; Luo X; Wei H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Feb; 19(1):67-71. PubMed ID: 10453556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
